American Journal of Cardiology
Volume 103, Issue 3 , Pages 333-337, 1 February 2009

Association of Leukocyte and Neutrophil Counts With Infarct Size, Left Ventricular Function and Outcomes After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

  • Stanley Chia, MD

      Affiliations

    • Heart Center, Massachusetts General Hospital, Boston, Massachusetts
  • ,
  • John T. Nagurney, MD, MPH

      Affiliations

    • Department of Emergency, Massachusetts General Hospital, Boston, Massachusetts
  • ,
  • David F.M. Brown, MD

      Affiliations

    • Department of Emergency, Massachusetts General Hospital, Boston, Massachusetts
  • ,
  • O. Christopher Raffel, MB, ChB

      Affiliations

    • Heart Center, Massachusetts General Hospital, Boston, Massachusetts
  • ,
  • Fabian Bamberg, MD, MPH

      Affiliations

    • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts
  • ,
  • Fred Senatore, MD, PhD

      Affiliations

    • Mitsubishi Pharma America, Warren, New Jersey
  • ,
  • Frans J. Th. Wackers, MD, PhD

      Affiliations

    • Cardiovascular Nuclear Imaging and Stress Laboratories, Yale University School of Medicine, New Haven, Connecticut
  • ,
  • Ik-Kyung Jang, MD, PhD

      Affiliations

    • Heart Center, Massachusetts General Hospital, Boston, Massachusetts
    • Corresponding Author InformationCorresponding author: Tel: 617-726-9226; fax: 617-726-7419

Received 13 August 2008; received in revised form 23 September 2008; accepted 23 September 2008. published online 17 November 2008.

Elevated leukocyte count during ST-segment elevation myocardial infarction is associated with adverse clinical outcomes. Whether increased leukocyte count after primary percutaneous coronary intervention (PCI) directly reflects larger infarct size and left ventricular impairment is not known. The aim of this study was to assess the relation between leukocyte and neutrophil counts with infarct size and the left ventricular ejection fraction (LVEF) after primary PCI. Three hundred sixty-three patients from the Evaluation of MCC-135 for Left Ventricular Salvage in Acute Myocardial Infarction (EVOLVE) study, a randomized, double-blind, placebo-controlled trial assessing the efficacy of intracellular calcium modulator as an adjunct to primary PCI in patients with first ST-segment elevation myocardial infarctions, were evaluated. Total and differential leukocyte counts were measured before and serially after PCI. Infarct size and the LVEF were assessed using single-photon emission computed tomography after 5 and 30 days, and patients were followed up to 180 days. Total leukocyte and neutrophil counts obtained 24 hours after PCI were significantly correlated with infarct size (r = 0.34 and 0.37, respectively, p <0.001) and inversely correlated with the LVEF (r = −0.20 and −0.22, respectively, p <0.001). Patients with elevated leukocyte and neutrophil counts had larger infarct sizes (12.5% vs 5% and 13.5% vs 5%, respectively, p <0.001). The highest neutrophil quartile was associated with increased 180-day composite cardiac events (19% vs 20% vs 23% vs 45%, log-rank p <0.001). Elevated leukocyte and neutrophil counts independently predicted adverse cardiac events (hazard ratios 2.5 and 2.2, respectively, p = 0.001). In conclusion, elevated leukocyte and neutrophil counts after primary PCI in patients with ST-segment elevation myocardial infarctions are directly related to myocardial infarct size and the LVEF and are independent predictors of cardiovascular outcomes.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Chia is the recipient of the National Medical Research Council Medical Research Fellowship and Health Manpower Development Program Fellowship, Singapore. The Evaluation of MCC-135 for Left Ventricular Salvage in Acute Myocardial Infarction (EVOLVE) study was supported by a grant from Mitsubishi Pharma Corporation, Osaka, Japan.

PII: S0002-9149(08)01701-3

doi:10.1016/j.amjcard.2008.09.085

American Journal of Cardiology
Volume 103, Issue 3 , Pages 333-337, 1 February 2009